CALLIDITAS THERAPEUTICS
Calliditas Therapeutics AB is a specialty pharmaceutical company based in Stockholm, Sweden. It is focused on developing high quality pharmaceutical products for patients with a significant unmet medical need in niche indications, in which Calliditas can partially or completely participate in the commercialization efforts. Calliditas is focused on the development and commercialization of the product candidate Nefecon, a unique two step formulation optimized to combine a time lag effect with a co... ncentrated release of the active substance budesonide, within a designated target area. This patented, locally acting formulation is intended for treatment of patients with the inflammatory renal disease IgA nephropathy (IgAN). Calliditas is running a global Phase 3 study within IgAN and aims to commercialize Nefecon in the United States.
CALLIDITAS THERAPEUTICS
Industry:
Biotechnology Medical Device Pharmaceutical
Founded:
1991-01-01
Address:
Stockholm, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.calliditas.se
Total Employee:
51+
Status:
Active
Contact:
(468)411-3005
Email Addresses:
[email protected]
Total Funding:
108.2 M USD
Technology used in webpage:
Google Maps Google Maps API Cloudmore
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Catalyst Biosciences
Catalyst Biosciences is a drug r and d company creating catalytic biopharmaceutical products based on engineered human proteases.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Palisade Bio
Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-08-13 | Genkyotex | Genkyotex acquired by Calliditas Therapeutics | 20.3 M USD |
Investors List
Kreos Capital
Kreos Capital investment in Debt Financing - Calliditas Therapeutics
Industrifonden
Industrifonden investment in Series C - Calliditas Therapeutics
Industrifonden
Industrifonden investment in Venture Round - Calliditas Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2020-04-06 | Calliditas appoints new Chief Medical Officer |
Official Site Inspections
http://www.calliditas.se Semrush global rank: 2.37 M Semrush visits lastest month: 7.8 K
- Host name: 104.18.22.112
- IP address: 104.18.22.112
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Calliditas Therapeutics"
Calliditas strengthens its US Commercial Organization
Renée Aguiar-Lucander, CEO, Calliditas Email: [email protected] Telephone: +46 722 52 10 06 Mikael Widell, Head of Communications Email: [email protected] …See details»
About Us – Calliditas Therapeutics AB
Calliditas is dedicated to expanding treatment options and establishing new standards of care for people with rare diseases. By drawing on our expertise in pharmaceutical product …See details»
Calliditas Therapeutics - Crunchbase Company Profile …
Calliditas Therapeutics AB is a specialty pharmaceutical company based in Stockholm, Sweden. It is focused on developing high quality pharmaceutical …See details»
About the website – Calliditas Therapeutics AB
Calliditas is a commercial stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and …See details»
Calliditas Therapeutics | LinkedIn
Calliditas Therapeutics | 12 091 följare på LinkedIn. Pioneering treatments for rare diseases. We harness scientific & commercial expertise to improve the lives of patients. | Calliditas …See details»
Calliditas Therapeutics – Wikipedia
Calliditas Therapeutics AB är ett svenskt, tidigare börsnoterat, läkemedelsföretag, som utvecklar läkemedel för njur- och leversjukdomar, bland andra ett specialistläkemedel mot …See details»
Calliditas Therapeutics - Overview, News & Similar companies
Jul 21, 2024 Notice of extraordinary meeting of Calliditas Therapeutics AB (publ) The shareholders of Calliditas Therapeutics AB (publ) (“Calliditas Therapeutics”), Reg. No. 556659 …See details»
Full List of Biotech Companies in Geneva (2025)
Feb 8, 2025 Geneva is also home to key global health institutions such as the Red Cross and the World Health Organization. Other important non-profit research institutions like Drugs for …See details»
Calliditas Therapeutics AB - Kungsbron 1, Stockholm - Hitta.se
Calliditas Therapeutics AB gick med förlust (2023) Calliditas Therapeutics AB gick med förlust, -273 518 000 kr. Calliditas Therapeutics AB ökade sin omsättning med 43,54% senaste …See details»
Associate Director/Director, US Thought Leader Liaison (TX/LA)
Calliditas, an ambitious pharmaceutical company is growing! To match our exciting growth plans we're looking for new employees to join our journey. ... Strong strategic and tactical planning, …See details»
Calliditas Therapeutics - Contacts, Employees, Board Members, …
Organization. Calliditas Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 7. Number of …See details»
Om Calliditas Therapeutics AB - Hitta.se
Hitta information om Calliditas Therapeutics AB. Företaget gick med förlust år 2023, omsättning 1 025 844 tkr. Telefon: 070-535 07 ..See details»
Calliditas Therapeutics : strengthens its US Commercial and …
Mar 8, 2021 Calliditas Therapeutics AB today announced the appointment of three industry veterans: Warren Brooks, PhD, as Vice President of US Medical Affairs, Teona Johnson as …See details»
Calliditas Therapeutics - Cision News
Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) meddelar idag att årsredovisningen för 2023 nu finns tillgänglig på bolagets hemsida www.calliditas.se. För mer …See details»
Calliditas Therapeutics AB - Cruelty Free Investing
Calliditas Therapeutics AB, formerly Pharmalink AB, is a Sweden-based specialty pharmaceutical company. It is focused on the development and commercialization of its product candidate …See details»
Career at Calliditas - Calliditas Therapeutics
Calliditas Therapeutics and our selected partners use cookies and similar technologies (together “cookies”) that are necessary to present this website, and to ensure you get the best …See details»
MFN.se > Calliditas Therapeutics > Statement by the Board of …
May 28, 2024 Background This statement is made by the Board of Directors (the "Board") of Calliditas Therapeutics AB (publ) ("Calliditas" or the "Company") pursuant to section II.19 of …See details»
Kallelse till extra bolagsstämma i Calliditas Therapeutics AB (publ)
Anmäla sig per post till Calliditas Therapeutics AB (publ), Extra Bolagsstämma 2024, c/o Euroclear Sweden, Box 191, 101 23 Stockholm eller via e-post till . …See details»
Calliditas Therapeutics AB (Calliditas Therapeutics AB) - 药物管线_ …
了解Calliditas Therapeutics AB (Calliditas Therapeutics AB)公司的药物管线，治疗领域，技术平台，以及它的20项临床试验, 222篇新闻，疾病领域:血液及淋巴系统疾病，肿瘤，免疫系统疾 …See details»
Calliditas Aktie 2025 - CALTX - Webbinvestor.se
Fördelar med att investera i Calliditas Aktie. 1. Innovativ produktportfölj: Calliditas erbjuder innovativa läkemedelsprodukter inom områden som njursjukdomar och leveråkommor. 2. …See details»